Hangzhi Liu1, Xinyan Wang1, Chen Zhang2, Thorsten Feiweier3, Xiaohong Chen4, and Junfang Xian1
1Department of Radiology, Beijing Tongren Hospital, Capital Medical University, Beijing, China, Beijing, China, 2MR collaborations, Siemens Healthcare, Beijing, China, Beijing, China, 3Siemens Healthcare GmbH,Neurology Applications Development, Erlangen, Germany, Erlangen, Germany, 4Department of Otolaryngology Head and Neck Surgery, Beijing Tongren Hospital, Capital Medical University, China, Beijing, China
Synopsis
Keywords: Head & Neck/ENT, Head & Neck/ENT
This
study investigated the feasibility of IMPULSED(Imaging Microstructural
Parameters Using Limited Spectrally Edited Diffusion) to evaluate cell
microstructure of head and neck squamous cell carcinoma. The results showed
that mean cell diameter, extracellular diffusion coefficient and intracellular
volume fraction are 9.47±3.33 µm,1.95±1.04μm²/ms and 0.23±0.14% respectively
and consistent with the previous pathological reports. Patients with cervical
lymph node metastases had significantly smaller mean cell diameters than those
without metastases. Mean cell diameter decreased with increasing cycles of
immunotherapy. This suggests that IMPULSED can quantitatively
characterize cell properties of tumor in head and neck squamous cell carcinoma
patients.
Introduction
Head
and neck squamous cell carcinoma (HNSCC) accounts for 90% of head and neck
tumors1. Despite advances in
surgery and chemotherapy, the median overall survival of patients with
recurrent or metastatic HNSCC is only 10–13 months2. In recent years, cancer immunotherapies
have emerged as effective treatment options for a variety of advanced cancers
including head and neck squamous cell carcinomas3. Identifying of patients who do not respond to immunotherapy at the initiation or early stage of treatment can
prompt the discontinuation of ineffective therapy. However, immunotherapies
have demonstrated unique response patterns such as pseudoprogression which may be
misdiagnosed as progressive disease by traditional response criteria4 and lead to effective
treatment discontinuation. The pseudoprogression is a result of increased
cytotoxic T cell infiltration into tumors5. Therefore,
non-invasive and longitudinal monitoring of T cell infiltration are important
for immunotherapies effects evaluation. The concept that
sufficiently large influx of tumor infiltrating T cells, which have a smaller
diameter than cancer cells, will decrease the average size of cells within a
volume has been validated in a mouse model of colon adenocarcinoma6. In this study, we tried to validate this
concept and quantify the microstructure characterization including cell
diameter by time-dependent diffusion MRI in patients with HNSCC.Method
This study recruited
8 HNSCC patients including 5 hypopharyngeal carcinoma,1 nasopharyngeal
carcinoma,1oropharynx carcinoma and 1 laryngeal carcinoma. Six of the eight
patients had lymph node metastasis. All patients underwent MRI on a 3.0 T (MAGNETOM
Prisma, Siemens Healthcare, Erlangen, Germany) before surgery. The
time-dependent diffusion MRI technique requires the acquisition of diffusion
MRI signals at different diffusion times to capture the time dependence in the
different microstructural compositions of diffusion by using oscillatory
gradient spin echo (OGSE) and pulsed gradient spin echo sequences. The
parameters are as follows: TR=3000ms; TE=118ms; FOV=250
× 250 mm2; matrix=162×162, number of slices =20, slice thickness=5.0 mm. OGSE
data were acquired at oscillating frequencies of 50Hz(2 cycles, b=100,200and
300sec/mm2) and 25Hz(1 cycle ,b= 250,500,750 and 1000sec/mm2),
and pulsed-gradient spin-echo-at diffusion duration and separation of 8msec and
46msec, respectively(b=250,500,750,1000,1400 and 1800sec/mm2). Total
scanning time was less than 15 minutes. The parameter maps of mean
cell diameter(d),
intracellular volume fraction(Vin),
and extracellular diffusion coefficient(Dex)were
generated (Fig 1). Three different regions of interest (ROI)methods were drawn on
the parameter maps excluding the boundary voxels to avoid the partial volume
effect: (1) the ROI was drawn on the largest tumor section area; (2) a small
ROI (area range, 20 mm2) was placed at the center of the largest
slice of the tumor ;(3)
a hollow ROI was drawn along the edge of the largest
slice of the tumor.
The parameters were recorded as dCenter(dC),
dEdge(dE), dLargestSlice(dLS), DexCenter(DexC),
DexEdge(DexE), DexLargestSlice(DexLS), VinCenter(VinC),
VinEdge(VinE) and VinLargestSlice(VinLS). A schematic
illustration of the three ROI selection methods was shown in Fig 2. The
measurements derived from three ROI method for Vin, d and Dex
were compared using One-way Anova test. Differences in the quantitative parameters
between patients with and without regional lymph nodes metastases were compared
using Student t test.
All statistical analyses were performed using SPSS
25.0 (SPSS, Chicago, IL, USA) and statistical significance
was set at P<0.05.Result
The
d for head and neck squamous cell
carcinoma was about 9.47±3.33 µm. The Dex and Vin were about 1.95±1.04μm²/ms
and 0.23±0.14%, respectively. Quantitative microstructure mapping of d, Dex
and Vin from a patient with hypopharyngeal cancer who underwent two
cycles of immunotherapy was shown in Fig 3. Note the d of the tumor decreased gradually with increasing treatment cycles,
although the primary tumor remained stable and metastatic lymph nodes are
enlarged after one cycle of immunotherapy. There was no significant difference
in d, Dex and Vin between three ROI method respectively(P>0.05)
(Table 1). The
d values of patients with regional lymph nodes metastases were
significantly smaller than those without metastases respectively(P<0.05)
(Table 2). There was no significant difference in Dex and Vin between
patients with and without metastases (P>0.05) (Table 2).Discussion
We
successfully applied the time-dependent diffusion sequence in the head and neck squamous cell carcinoma, and the quantitative parameters derived in our
study were consistent with the previous pathological reports7. The d values derived from the
time-dependent diffusion sequence decreased gradually with increasing treatment
cycles in one patient with hypopharyngeal carcinoma. The d values of patients with regional lymph
node metastases was significantly smaller than that of patients without
metastases. However, the result needs to be validated by larger samplesConclusion
The
novel time-dependent diffusion MR technique can quantitatively characterize cellular
properties of tumors in patients with head and neck squamous cell carcinoma, especially the mean
cell size of tumors, which may contribute to a better understanding of
immunotherapies, including appropriate patient selection, therapy sequence and response
monitoringAcknowledgements
National Natural Science Foundation of China(82202100); Beijing Municipal Administration of Hospitals’ Ascent Plan (DFL20190203); Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support (ZYLX201704)
References
1. Gupta
B, Johnson NW, Kumar N. Global Epidemiology of Head and Neck Cancers: A
Continuing Challenge. Oncology 2016;91(1):13-23.
2. Brockstein B, Haraf DJ,
Rademaker AW, et al. Patterns of failure, prognostic factors and survival in
locoregionally advanced head and neck
cancer treated with concomitant chemoradiotherapy: a 9-year, 337-patient, multi-institutional experience.
Ann Oncol 2004;15(8):1179-86.
3. Meric-Bernstam F, Larkin J,
Tabernero J, Bonini C. Enhancing anti-tumour efficacy with immunotherapy
combinations. Lancet 2021;397(10278):1010-1022.
4. Nishino
M, Hatabu H, Hodi FS. Imaging of Cancer Immunotherapy: Current Approaches and
Future Directions. Radiology 2019;290(1):9-22.
5. Cho J, Kim SJ, Park WY, et al.
Immune subtyping of extranodal NK/T-cell lymphoma: a new biomarker and an
immune shift during disease progression.
Mod Pathol 2020;33(4):603-615.
6. Jiang
X, Dudzinski S, Beckermann KE, et al. MRI of tumor T cell infiltration in
response to checkpoint inhibitor therapy. J Immunother Cancer 2020;8(1).
7. Dobroś W, Gil K, Ryś J,
Stanisz-Wallis K. Nuclear morphometry for the prediction of regional lymph
nodes metastases in patients with cancer of the larynx. Otolaryngology–Head and Neck Surgery 2000;123(6):770-774.